<bill session="112" type="h" number="4209" updated="2019-11-15T21:15:48Z">
  <state datetime="2012-03-19">REFERRED</state>
  <status>
    <introduced datetime="2012-03-19"/>
  </status>
  <introduced datetime="2012-03-19"/>
  <titles>
    <title type="short" as="introduced">Patients' Access to Treatments Act of 2012</title>
    <title type="display">Patients' Access to Treatments Act of 2012</title>
    <title type="official" as="introduced">To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001180"/>
  <cosponsors>
    <cosponsor bioguide_id="B000013" joined="2012-05-09"/>
    <cosponsor bioguide_id="B000208" joined="2012-04-19"/>
    <cosponsor bioguide_id="B001242" joined="2012-09-21"/>
    <cosponsor bioguide_id="B001278" joined="2012-09-21"/>
    <cosponsor bioguide_id="B001244" joined="2012-04-24"/>
    <cosponsor bioguide_id="B000652" joined="2012-09-12"/>
    <cosponsor bioguide_id="C001047" joined="2012-09-20"/>
    <cosponsor bioguide_id="C001036" joined="2012-03-19"/>
    <cosponsor bioguide_id="C001084" joined="2012-06-05"/>
    <cosponsor bioguide_id="C000714" joined="2012-04-16"/>
    <cosponsor bioguide_id="C001069" joined="2012-09-12"/>
    <cosponsor bioguide_id="C001045" joined="2012-04-24"/>
    <cosponsor bioguide_id="C001063" joined="2012-03-19"/>
    <cosponsor bioguide_id="D000096" joined="2012-09-20"/>
    <cosponsor bioguide_id="D000598" joined="2012-07-19"/>
    <cosponsor bioguide_id="D000191" joined="2012-12-12"/>
    <cosponsor bioguide_id="D000610" joined="2012-04-19"/>
    <cosponsor bioguide_id="F000030" joined="2012-04-19"/>
    <cosponsor bioguide_id="F000339" joined="2012-03-19"/>
    <cosponsor bioguide_id="G000549" joined="2012-09-12"/>
    <cosponsor bioguide_id="H001045" joined="2012-03-28"/>
    <cosponsor bioguide_id="H001032" joined="2012-09-12"/>
    <cosponsor bioguide_id="J000283" joined="2012-04-24"/>
    <cosponsor bioguide_id="J000288" joined="2012-07-19"/>
    <cosponsor bioguide_id="L000559" joined="2012-05-09"/>
    <cosponsor bioguide_id="M000133" joined="2012-09-20"/>
    <cosponsor bioguide_id="M000404" joined="2012-11-30"/>
    <cosponsor bioguide_id="M000312" joined="2012-04-16"/>
    <cosponsor bioguide_id="M001149" joined="2012-09-12"/>
    <cosponsor bioguide_id="M000933" joined="2012-06-07"/>
    <cosponsor bioguide_id="P000099" joined="2012-09-12"/>
    <cosponsor bioguide_id="P000597" joined="2012-05-09"/>
    <cosponsor bioguide_id="R000053" joined="2012-09-12"/>
    <cosponsor bioguide_id="R000462" joined="2012-04-19"/>
    <cosponsor bioguide_id="R000486" joined="2012-05-09"/>
    <cosponsor bioguide_id="R000594" joined="2012-09-12"/>
    <cosponsor bioguide_id="T000469" joined="2012-05-09"/>
    <cosponsor bioguide_id="T000326" joined="2012-09-20"/>
    <cosponsor bioguide_id="W000800" joined="2012-12-11"/>
    <cosponsor bioguide_id="W000672" joined="2012-09-12"/>
    <cosponsor bioguide_id="W000738" joined="2012-09-12"/>
    <cosponsor bioguide_id="Y000031" joined="2012-03-19"/>
    <cosponsor bioguide_id="Y000033" joined="2012-05-09"/>
  </cosponsors>
  <actions>
    <action datetime="2012-03-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2012-03-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Employee benefits and pensions"/>
    <term name="Health care costs and insurance"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2012-07-03T20:05:53Z" status="Introduced in House">Patients' Access to Treatments Act of 2012 - Amends the Public Health Service Act to prohibit a health plan offering group or individual health insurance that provides coverage for prescription drugs and uses a formulary or other tiered cost-sharing structure from imposing co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of such requirements applicable to prescription drugs in a non-preferred brand drug tier.

Provides that if a formulary used by such a health plan contains more than one non-preferred brand drug tier, such prohibition shall be applied with respect to the non-preferred brand drug tier for which beneficiary cost-sharing is lowest.

Defines: (1) "non-preferred brand drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs in the plan's formulary, that are prescription drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary and that are prescription drugs.</summary>
</bill>
